Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.00
Ask:
1.10
Spread: 0.10 (10.00%)
Market Cap: £25.80m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

AGM Statement

24 Aug 2011 07:00

RNS Number : 9007M
Provexis PLC
24 August 2011
 



24 August 2011

Provexis plc

 

AGM Statement

 

Provexis plc ("Provexis" or the "Company"), the life-science business that develops, licenses and markets scientifically-proven functional food, sports nutrition and medical food technologies, will hold its Annual General Meeting in Reading later today.

 

At the meeting Dawson Buck, the non-executive Chairman of the Company, will give the following update on developments:

 

 "The Company has made major progress over the past 18 months, specifically with the commercialisation of its lead technology Fruitflow and the recent acquisition of Science in Sport ("SiS").

 

Following the announcement of the long-term Alliance with DSM Nutritional Products ("DSM") in June 2010, DSM has made good progress in marketing Fruitflow to a broad range of global markets, attracting positive interest from a wide range of global, multinational and national brand owners in the functional food and dietary supplement sectors. The Alliance expects to see initial revenues from Fruitflow commence in the coming months and the Company looks forward to updating shareholders on this matter as and when appropriate.

 

The Company acquired SiS in June 2011. The Board are very pleased with the business and the opportunities it presents to the enlarged group. The Board strongly believe that through targeted investment SiS will achieve significant like for like revenue growth and margin improvement. As part of this investment the Directors expect to transfer production and distribution to a larger facility later in the year, in line with growth plans for the business. Defined marketing and selling strategies, together with new product launches and efficiencies from the supply chain, will underpin sales and profit growth in the business during 2012.

 

The SiS business presents the Company with a number of opportunities to bring new products to market to support 2012 growth; consequently the Board is currently reviewing the overall project pipeline for the Company in order to allocate resource and capital in the most effective way, in line with our growth targets.

 

We have a busy year ahead of us, with the main focus of the executive team being on delivering revenues from Fruitflow and growing the sales and profitability of the SiS business. We have sufficient resources to hand to deliver our targets and I look forward to a year of strong progress."

 

-ends-

 

For further information please contact:

 

Stephen Moon, Chief Executive

Provexis plc Tel: 01753 833177

 

Bobbie Hilliam Tel: 020 7071 4317

Evolution Securities

 

Haggie Financial LLP: Tel: 020 7417 8989

Matthew Longbottom/Peter Rigby matthew.longbottom@haggie.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEXLFLFVFLBBB
Date   Source Headline
28th Feb 20117:00 amRNSDevelopment Agreement with DSM Nutritional Product
8th Feb 20114:35 pmRNSPrice Monitoring Extension
16th Dec 20107:00 amRNSINTERIM RESULTS
9th Dec 20107:00 amRNSNotice of Results
17th Nov 20107:00 amRNSFruitflow wins industry innovation awards
29th Oct 20107:00 amRNSTotal Voting Rights
27th Oct 20104:40 pmRNSSecond Price Monitoring Extn
27th Oct 20104:35 pmRNSPrice Monitoring Extension
14th Oct 20101:38 pmRNSHolding(s) in Company
11th Oct 201011:53 amRNSHolding(s) in Company
4th Oct 20107:00 amRNSIssue of Equity
13th Sep 20104:24 pmRNSHolding(s) in Company
9th Sep 20103:17 pmRNSResult of AGM
9th Sep 20107:00 amRNSAGM Statement
7th Sep 20104:40 pmRNSSecond Price Monitoring Extn
7th Sep 20104:35 pmRNSPrice Monitoring Extension
6th Sep 20104:35 pmRNSPrice Monitoring Extension
13th Aug 20107:00 amRNSAnnual report & accounts and notice of AGM
28th Jul 20104:40 pmRNSSecond Price Monitoring Extn
28th Jul 20104:35 pmRNSPrice Monitoring Extension
26th Jul 201011:35 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
26th Jul 20107:00 amRNSProduct Update
23rd Jul 20104:40 pmRNSSecond Price Monitoring Extn
23rd Jul 20104:35 pmRNSPrice Monitoring Extension
22nd Jul 20104:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20104:35 pmRNSPrice Monitoring Extension
14th Jul 20104:40 pmRNSSecond Price Monitoring Extn
14th Jul 20104:35 pmRNSPrice Monitoring Extension
8th Jul 20104:40 pmRNSSecond Price Monitoring Extn
8th Jul 20104:35 pmRNSPrice Monitoring Extension
28th Jun 20104:40 pmRNSSecond Price Monitoring Extn
28th Jun 20104:35 pmRNSPrice Monitoring Extension
22nd Jun 20107:00 amRNSDraw Down of Funds and Issue of Equity
15th Jun 20104:40 pmRNSSecond Price Monitoring Extn
15th Jun 20104:35 pmRNSPrice Monitoring Extension
10th Jun 20104:40 pmRNSSecond Price Monitoring Extn
10th Jun 20104:35 pmRNSPrice Monitoring Extension
1st Jun 20107:00 amRNSFinal Results
1st Jun 20107:00 amRNSAlliance agreement with DSM Nutritional Products
28th May 20103:20 pmRNSNotice of Results
26th Apr 20107:00 amRNSRe Agreement
21st Apr 20107:00 amRNSChange in major shareholding
21st Apr 20107:00 amRNSNotification of Major Interest in Shares
13th Apr 201012:01 pmRNSHolding(s) in Company
31st Mar 20104:35 pmRNSTotal Voting Rights
31st Mar 20107:00 amRNSCompletion of ?25m Equity Financing Facility
31st Mar 20107:00 amRNSPre-close trading update
9th Mar 20107:00 amRNSTrial Results
18th Feb 201011:30 amRNSHolding(s) in Company
12th Feb 20103:20 pmRNSDirector Shareholdings and Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.